Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio An announcement from Dr Reddy’s Laboratories ( (RDY)) is now available.

Shares of Dr. Reddy's Laboratories Ltd. 500124 rallied 1.30% to 1,219.65 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

Dr. Reddy's Laboratories Ltd. 500124 shares advanced 1.90% to 1,217.60 Indian rupees Friday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX ...

Wishing ISRO continued success in all future endeavors, Mr. Reddy hailed this milestone as a testament to India’s growing leadership in space exploration.

New Delhi: Shares of Dr Reddy’s Laboratories on Friday ended 5 per cent lower after the company’s third-quarter earnings failed to cheer investors. The stock tanked 5.01 per cent to settle at Rs 1,224 ...

Shares of Dr Reddy's Laboratories tumbled as much as 7 per cent during the trading session on Friday after the leading pharmaceuticals player reported a muted set of numbers in the December 2024 ...

Dr Reddy's Laboratories Stock Price: Dr Reddy's shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE). Listen to Story ...

Shares of Dr. Reddy's Laboratories Ltd. declined over 5% during Friday's early trading session after the company announced its December quarter results. The Q3 earnings revealed subdued numbers and ...

Stock Market Today: Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post-Q3 results that were announced after the market hours of Thursday. On Thursday ...

Dr. Reddy’s (DRRD) Q3FY25 EBITDA was below our estimate. The base business margins and US sales ex of gRevlimid and one offs continued to remain weak. We have scale up base business margins from ...

PSAI Business Revenue: USD97 million, 3% YoY growth, 3% QoQ decline. Dr Reddy's Laboratories Ltd (NYSE:RDY) reported a double-digit top line growth of 16% year-on-year, driven by strong ...